Immatics

-$0.46 (-3.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.

About IMTX

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. The firm's clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCERâ„¢).

CEO
Harpreet Singh-Jasuja
Employees
198
Headquarters
Tuebingen, Baden Wuerttemberg
Founded
2000

IMTX Key Statistics

Market Cap
842.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
134.83K
High Today
$13.82
Low Today
$13.25
Open Price
$13.82
Volume
64.35K
52 Week High
$18.42
52 Week Low
$9.58

IMTX Earnings

-$0.54
-$0.36
-$0.18
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Dec 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure